Abstract:The tumor microenvironment (TME) is crucial in cancer progression and immunotherapy response. Optical imaging techniques provide a noninvasive, real time method to analyze immune cells in the TME, helping predict and monitor immunotherapy outcomes. This review highlights advancements in optical imaging for TME immunotherapy and its potential in clinical trials and personalized cancer treatment. Background The tumor microenvironment (TME) plays a critical role in cancer progression and response to immunotherapy. Immunotherapy targeting the immune system has emerged as a promising treatment modality, but challenges in understanding the TME limit its efficacy. Optical imaging strategies offer noninvasive, real‐time insights into the interactions between immune cells and the TME. Objective This review assesses the progress of optical imaging technologies in monitoring immunotherapy within the TME and explores their potential applications in clinical trials and personalized cancer treatment. Methods This is a comprehensive literature review based on the advances in optical imaging modalities including fluorescence imaging (FLI), bioluminescence imaging (BLI), and photoacoustic imaging (PAI). These modalities were analyzed for their capacity to provide high‐resolution, real‐time imaging of immune cell dynamics, tumor vasculature, and other critical components of the TME. Results Optical imaging techniques have shown significant potential in tracking immune cell infiltration, assessing immune checkpoint inhibitors, and visualizing drug delivery within the TME. Technologies like FLI and BLI are pivotal in tracking immune responses in preclinical models, while PAI provides functional imaging with deeper tissue penetration. The integration of these modalities with immunotherapy holds promise for improving treatment monitoring and outcomes. Conclusion Optical imaging is a powerful tool for understanding the complexities of the TME and optimizing immunotherapy. Further advancements in imaging technologies, combined with nanomaterial‐based approaches, could pave the way for enhanced diagnostic accuracy and therapeutic efficacy in cancer treatment.

Fluorescence Imaging of Tumor Immune Contexture in Immune Checkpoint Blockade Therapy.

Molecular Imaging for Cancer Immunotherapy: Seeing is Believing

The role of radiotherapy in tumor immunity and the potential of PET/CT in detecting the expression of PD-1/PD-L1

Positron Emission Tomography Molecular Imaging to Monitor Anti-Tumor Systemic Response for Immune Checkpoint Inhibitor Therapy

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments

NIR fluorescence imaging and treatment for cancer immunotherapy

Application of Molecular Imaging in Immune Checkpoints Therapy: from Response Assessment to Prognosis Prediction.

Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy

Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect

Applications of Intravital Imaging in Cancer Immunotherapy

Tumor Immune Checkpoints and Their Associated Inhibitors

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment

In Vivo Clinical Molecular Imaging of T Cell Activity.

Role of medical imaging for immune checkpoint blockade therapy: From response assessment to prognosis prediction

Emerging Biomaterials Imaging Antitumor Immune Response

Immunotherapy and the role of imaging

Progress of Molecular Imaging-guided Tumor Immunotherapy

Monitoring Immunotherapy With Optical Molecular Imaging

Molecular imaging of cell-based cancer immunotherapy.

[Advances in Imaging-Based Evaluation of Solid Tumors Treated With Immune Checkpoint Inhibitors]

Fluorescent imaging for cancer therapy and cancer gene therapy